Steven D. Macicek Purchases 12,000 Shares of American Vanguard Co. (NYSE:AVD) Stock

American Vanguard Co. (NYSE:AVD) Director Steven D. Macicek bought 12,000 shares of the business’s stock in a transaction on Friday, November 15th. The stock was acquired at an average cost of $5.97 per share, for a total transaction of $71,640.00. Following the completion of the transaction, the director now owns 31,218 shares in the company, valued at $186,371.46. This represents a 62.44 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

American Vanguard Stock Performance

AVD opened at $6.19 on Thursday. The stock has a market cap of $178.20 million, a price-to-earnings ratio of -6.01 and a beta of 0.88. The company has a quick ratio of 0.79, a current ratio of 1.89 and a debt-to-equity ratio of 0.55. American Vanguard Co. has a 12-month low of $4.95 and a 12-month high of $14.28. The business has a 50 day moving average of $5.53 and a 200-day moving average of $7.25.

Institutional Investors Weigh In On American Vanguard

Several hedge funds have recently modified their holdings of the company. Barclays PLC increased its position in American Vanguard by 59.3% in the 3rd quarter. Barclays PLC now owns 73,112 shares of the basic materials company’s stock valued at $388,000 after buying an additional 27,229 shares in the last quarter. XTX Topco Ltd purchased a new position in American Vanguard in the third quarter valued at approximately $104,000. Quantinno Capital Management LP purchased a new stake in shares of American Vanguard during the third quarter worth $89,000. Jacobs Levy Equity Management Inc. increased its holdings in shares of American Vanguard by 4.5% in the third quarter. Jacobs Levy Equity Management Inc. now owns 271,225 shares of the basic materials company’s stock worth $1,437,000 after purchasing an additional 11,751 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in American Vanguard in the third quarter valued at $2,351,000. Institutional investors and hedge funds own 79.04% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised American Vanguard from a “sell” rating to a “hold” rating in a report on Wednesday, September 25th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, American Vanguard currently has an average rating of “Moderate Buy” and a consensus price target of $16.67.

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.